Association between the HLA-B 15:02 allele and carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Han individuals of northeastern China

Pharmacological Reports

Volumn 65, Issue 5, 2013, Pages 1256-1262

  He, Xiao Jing ^a   Jian, Ling Yan ^a   He, Xiao Lin ^b   Wu, Yan ^a   Xu, Yuan Yuan ^a   Sun, Xiao Jie ^c   Miao, Li Yan ^d   Zhao, Li Mei ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b SHENYANG MEDICAL COLLEGE   (China)

^c Fourth People' Hospital   (China)

^d SOOCHOW UNIVERSITY   (China)

Author keywords

Carbamazepine; Han individuals of northeastern China; HLA B 15:02; SJS TEN

Indexed keywords

CARBAMAZEPINE; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; EPILEPSY; ETHNIC GROUP; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HLA A GENE; HLA B GENE; HLA C GENE; HLA DQB1 GENE; HLA DRB1 GENE; HUMAN; MALE; PHARMACOGENETICS; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; ASIAN CONTINENTAL ANCESTRY GROUP; CARBAMAZEPINE; CASE-CONTROL STUDIES; CHILD; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-B15 ANTIGEN; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMERASE CHAIN REACTION; RISK FACTORS; SEQUENCE ANALYSIS, DNA; STEVENS-JOHNSON SYNDROME; YOUNG ADULT;

EID: 84894133297     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)71483-X     Document Type: Article

References (28)

1. Alfirevic A, Jorgensen AL, Williamson PR, Chadwick DW, Park BK, Pirmohamed M: HLA-B locus in Caucasian patients with carbamazepine hypersensitivity. Pharmacogenomics, 2006, 7, 813-818. (Pubitemid 44446732)
2. Baszczyk B, Szpringer M, Czuczwar SJ, Lasoñ W: Single centre 20 year survey of antiepileptic drug-induced hypersensitivity reactions. Pharmacol Rep, 2013, 65, 399-409.
3. Bunce M, O'Neill CM, Barnardo MC, Krausa P, Browning MJ, Morris PJ, Welsh KI: Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primers mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens, 1995, 46, 355-367. (Pubitemid 26001354)
4. Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT: Medical genetics: a marker for Stevens-Johnson syndrome. Nature, 2004, 428, 486.
5. Daar AS, Singer PA: Pharmacogenetics and geographical ancestry: implications for drug development and global health. Nat Rev Genet, 2005, 6, 241-246. (Pubitemid 40293034)
6. Ferrell PB Jr., McLeod HL: Carbamazepine, HLA-B1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. Pharmacogenomics, 2008, 9, 1543-1546.
7. Hung SI, Chung WH, Jee SH, Chen WC, Chang YT, Lee WR, Hu SL et al.: Genetic susceptibility to carbamazepine- induced cutaneous adverse drug reactions. Pharmacogenet Genomics, 2006, 16, 297-306.
8. Ikeda H, Takahashi Y, Yamazaki E, Fujiwara T, Kaniwa N, Saito Y, Aihara M et al.: HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions. Epilepsia, 2010, 51, 297-300.
9. Jewell NP: On the bias of commonly used measures of association for 2×2 tables. Biometrics, 1986, 42, 351-358.
10. Kamaliah MD, Zainal D, Mokhtar N, Nazmi N: Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in northeastern Malaysia. Int J Dermatol, 1998, 37, 520-523. (Pubitemid 28329047)
11. Kangwanshiratada O, Hirankarn N, Suphapeetiporn K, Shotelersuk V: Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients. J Dermatol, 2008, 10, 683-685.
12. Khoo AK, Foo CL: Toxic epidermal necrolysis in a burns centre: a 6-year review. Burns, 1996, 22, 275-278. (Pubitemid 26164130)
13. Locharernkul C, Loplumlert J, Limotai C, Korkij W, Desudchit T, Tongkobpetch S, Kangwanshiratada O et al.: Carbamazepine and phenytoin induced Stevens- Johnson syndrome is associated with HLA-B1502 allele in Thai population. Epilepsia, 2008, 49, 2087-2091.
14. Lonjou C, Thomas L, Borot N, Ledger N, de Toma C, LeLouet H, Graf E et al.: A marker for Stevens-Johnson syndrome: ethnicity matters. Pharmacogenomics J, 2006, 6, 265-268. (Pubitemid 44137953)
15. Man CB, Kwan P, Baum L, Yu E, Lau KM, Cheng AS, Ng MH: Association between HLA-B1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia, 2007, 48, 1015-1018. (Pubitemid 46763406)
16. McCormack M, Alfirevic A, Bourgeois S, Farrell JJ, Kasperaviè iuté D, Carrington M, Sills GJ et al.: HLA-A3101 and carbamazepine- induced hypersensitivity reactions in Europeans. N Eng J Med, 2011, 24, 1134-1143.
17. Mehta TY, Prajapati LM, Mittal B, Joshi CG, Sheth JJ, Patel DB, Dave DM, Goyal RK: Association of HLA-B1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians. Indian J Dermatol Venereol Leprol, 2009, 75, 579-582.
18. Nebert DW: Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist? Clin Genet, 1999, 56, 247-258.
19. Ozeki T, Mushiroda T, Yowang A, Takahashi A, Kubo M, Shirakata Y, Ikezawa Z et al.: Genome-wide association study identifies HLA-A3101 allele as a genetic factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population. Hum Mol Genet, 2011, 20, 1034-1041.
20. Roujeau JC, Bracq C, Huyn NT, Chaussalet E, Raffin C, Duedari N: HLA phenotypes and bullous cutaneous reactions to drugs. Tissue Antigens, 1986, 28, 251-254. (Pubitemid 17201461)
21. Sun D, Shi YW, Liu ZS, Liao WP, Wang FL, Wu GF, Hu JS, He CY: Hypersensitivity syndrome reactions to antiepileptic drugs, clinical characteristic and association with HLA-B1502 (Chinese). Chinese Med J, 2010, 90, 2763-2766.
22. Svensson CK, Cowen EW, Gaspari AA: Cutaneous drug reactions. Pharmacol Rev, 2000, 53, 357-379. (Pubitemid 32852017)
23. Then SM, Rani ZZ, Raymond AA, Ratnaninqrum S, Jamal R: Frequency of the HLA-B1502 allele contribut- ing to carbamazepine-induced hypersensitivity reactions in a cohort of Malaysian epilepsy patients. Asian Pac J Allergy Immunol, 2011, 29, 290-293.
24. Ueta M, Tokunaga K, Sotozono C, Inatomi T, Yabe T, Matsushita M, Mitsuishi Y, Kinoshita S: HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese. Mol Vis, 2008, 14, 550-555. (Pubitemid 351472356)
25. Wang Q, Zhou JQ, Zhou LM, Chen ZY, Fang ZY, Chen SD, Yang LB et al.: Association between HLA-B1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland. Seizure, 2011, 20, 446-448.
26. Wu XT, Hu FY, An DM, Yan B, Jiang X, Kwan P, Stefan H, Zhou D: Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B1502 allele among patients in central China. Epilepsy Behav, 2010, 19, 405-408.
27. The Allele Frequency Net Database [http://www.allelefrequencies. net/]
28. Zhang Y, Wang J, Zhao LM, Peng W, Shen GQ, Xue L, Zheng XX et al.: Strong association between HLA-B1502 and carbamazepine-induced Stevens- Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients. Eur J Clin Pharmacol, 2011, 67, 885-887.